Nuage Therapeutics — Seed · €12M

Nuage Therapeutics, an IRB Barcelona and ICREA spin-off based at the Barcelona Science Park, raised €12 million in seed financing to advance its drug-discovery engine for small-molecule modulators of intrinsically disordered proteins, initially targeting castration-resistant prostate cancer. The round was co-led by Sofinnova Partners and Asabys Partners with no single lead, with participation from Innvierte (CDTI Innovación) and BStartup.